Serious Adverse Events Associated with Anti-Tumor Necrosis Factor Alpha Agents in Pediatric-Onset Inflammatory Bowel Disease and Juvenile Idiopathic Arthritis in A Real-Life Setting
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serious Adverse Events Associated with Anti-Tumor Necrosis Factor Alpha Agents in Pediatric-Onset Inflammatory Bowel Disease and Juvenile Idiopathic Arthritis in A Real-Life Setting
Authors
Keywords
-
Journal
PEDIATRIC DRUGS
Volume 20, Issue 2, Pages 165-171
Publisher
Springer Nature
Online
2017-12-06
DOI
10.1007/s40272-017-0267-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept
- (2016) Sara Verazza et al. Pediatric Rheumatology
- Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA)
- (2015) Jens Klotsche et al. ANNALS OF THE RHEUMATIC DISEASES
- Anti-TNF therapy for paediatric IBD: the Scottish national experience
- (2015) F L Cameron et al. ARCHIVES OF DISEASE IN CHILDHOOD
- Biologic-Associated Infections in Pediatric Rheumatology
- (2015) Gerd Horneff Current Rheumatology Reports
- Risks of Serious Infection or Lymphoma With Anti–Tumor Necrosis Factor Therapy for Pediatric Inflammatory Bowel Disease: A Systematic Review
- (2014) Parambir S. Dulai et al. Clinical Gastroenterology and Hepatology
- Safety and efficacy of etanercept in children with the JIA categories extended oligoarthritis, enthesitis-related arthritis and psoriasis arthritis
- (2014) D. Windschall et al. CLINICAL RHEUMATOLOGY
- A 10-Year, Single Tertiary Care Center Experience on the Durability of Infliximab in Pediatric Inflammatory Bowel Disease
- (2014) Elaheh Vahabnezhad et al. INFLAMMATORY BOWEL DISEASES
- Occurrence of adverse events in patients with JIA receiving biologic agents: long-term follow-up in a real-life setting
- (2014) Maarit Tarkiainen et al. RHEUMATOLOGY
- Efficacy and Safety of Adalimumab as the First and Second Biologic Agent in Juvenile Idiopathic Arthritis: The German Biologics JIA Registry
- (2014) Heinrike Schmeling et al. Arthritis & Rheumatology
- Infections in Children and Adolescents With Juvenile Idiopathic Arthritis and Inflammatory Bowel Disease Treated With Tumor Necrosis Factor- Inhibitors: Systematic Review of the Literature
- (2013) S. S. Toussi et al. CLINICAL INFECTIOUS DISEASES
- P436 Malignancies in children receiving infliximab and other inflammatory bowel disease therapies: an inflammatory bowel disease multicenter, prospective, long-term registry of pediatric patients (DEVELOP) registry data
- (2013) R. Colletti et al. Journal of Crohns & Colitis
- 15 Serious infections and associated risk factors in patients receiving infliximab and immunotherapies for children with inflammatory bowel disease: DEVELOP registry data
- (2013) R. Baldassano et al. Journal of Crohns & Colitis
- Improvement in Health-Related Quality of Life for Children With Juvenile Idiopathic Arthritis After Start of Treatment With Etanercept
- (2013) Jens Klotsche et al. ARTHRITIS CARE & RESEARCH
- What are the immunological consequences of long-term use of biological therapies for juvenile idiopathic arthritis?
- (2013) Joost F Swart et al. ARTHRITIS RESEARCH & THERAPY
- Lupus-Like Syndrome Attributable to Anti—Tumor Necrosis Factor α Therapy in 14 Patients During an 8-Year Period at Mayo Clinic
- (2012) David A. Wetter et al. MAYO CLINIC PROCEEDINGS
- Differences in phenotype and disease course in adult and paediatric inflammatory bowel disease - a population-based study
- (2011) C. Jakobsen et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Tumor necrosis factor α blockers and malignancy in children: Forty-eight cases reported to the food and drug administration
- (2010) Peter Diak et al. ARTHRITIS AND RHEUMATISM
- Infliximab-related Vasculitis in Patients Affected by Ulcerative Colitis
- (2010) Serena Pastore et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Anti-TNF-induced lupus
- (2009) E. L. Williams et al. RHEUMATOLOGY
- Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register
- (2008) F H M Prince et al. ANNALS OF THE RHEUMATIC DISEASES
- Focus on adverse events of tumour necrosis factor blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients
- (2007) V Gerloni et al. ANNALS OF THE RHEUMATIC DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now